LGVN实时信号 | 通过Getagraph.com最大化利润

Live Chart Being Loaded With Signals

Commentary (4 May 2024 @ 04:00):

Stats
今日成交量	395 492
平均成交量	2.21M
市值	8.40M
EPS	$0 ( 2024-02-27 )
下一个收益日期	( $-2.01 ) 2024-05-10
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.170
ATR14	$0.00900 (0.51%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-11	Hare Joshua	Buy	42 553	Class A Common Stock
2024-04-10	Hare Joshua	Buy	106 383	Class A Common Stock
2024-04-10	Hare Joshua	Buy	106 383	Warrant (right to buy)
2024-04-11	Hare Joshua	Buy	42 553	Warrant (right to buy)
2024-04-11	Hashad Mohamed Wa'el Ahmed	Buy	10 638	Class A Common Stock

INSIDER POWER
39.63
Last 100 transactions
Buy: 1 179 927 \| Sell: 679 611

音量相关性

長: 0.05 (neutral)

短: 0.59 (weak)

Signal:(46.527) Neutral

Longeveron Inc. Class A 相关性

10 最正相关
EVOK	0.972
VVOS	0.97
UXIN	0.968
CNSP	0.963
KXIN	0.962
AYLA	0.961
RIDE	0.961
AGRI	0.957
ASLE	0.957
BCAN	0.955

10 最负相关
BRIVU	-0.956
MSDA	-0.955
SGII	-0.947
RNLC	-0.947
KRUS	-0.944
STAY	-0.944
MASI	-0.941
TIOAU	-0.941
INBKZ	-0.94
ADTH	-0.939

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Longeveron Inc. Class A 相关性 - 货币/商品

0.35
( neutral )

0.38
( neutral )

0.00
( neutral )

0.33
( neutral )

0.32
( neutral )

Longeveron Inc. Class A 财务报表

Annual	2023
营收:	$709 000
毛利润:	$-725 000 (-102.26 %)
EPS:	$-9.85

FY	2023
营收:	$709 000
毛利润:	$-725 000 (-102.26 %)
EPS:	$-9.85

FY	2022
营收:	$1.22M
毛利润:	$497 000 (40.67 %)
EPS:	$-9.36

FY	2021
营收:	$1.31M
毛利润:	$590 000 (45.18 %)
EPS:	$-0.897

Financial Reports:

No articles found.

Longeveron Inc. Class A

Longeveron Inc., a clinical stage biotechnology company, develops cellular therapies for aging-related and life-threatening conditions. The company's lead investigational product is the LOMECEL-B, a cell-based therapy product that is derived from culture-expanded medicinal signaling cells that are sourced from bone marrow of young healthy adult donors. It is conducting Phase 1 and 2 clinical trials in various indications, such as aging frailty, alzheimer's disease, metabolic syndrome, acute respiratory distress syndrome, and hypoplastic left heart syndrome. The company was incorporated in 2014 and is based in Miami, Florida.

实时更新： Longeveron Inc. Class A [LGVN]

Upcoming Earnings Alert